STOCK TITAN

Farallon and Zone Holdings disclose ownership in Beta Bionics (BBNX) — 13G/A

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Beta Bionics, Inc. Schedule 13G/A Amendment No. 4 reports holdings by Farallon-related entities and Zone Healthcare Holdings, LLC. Zone Healthcare Holdings, LLC is shown with 2,560,220 shares (5.8%). Several Farallon funds and affiliated persons are shown with positions ranging from 28,440 to 436,671 shares. A group of Farallon individual reporting persons are each reported with 3,607,920 shares (8.1%) in the cover rows incorporated by reference.

The filing lists ownership, voting and dispositive power columns for each reporting person and includes standard disclaimers about beneficial ownership and group status under Section 240.13d-1(c). Signatures show the filing was executed by Hannah E. Dunn on 05/12/2026.

Positive

  • None.

Negative

  • None.
Zone Healthcare shares 2,560,220 shares reported on cover rows as 5.8% ownership
Farallon individual reporting persons 3,607,920 shares each reported as 8.1% ownership on cover rows
Farallon Capital Offshore Investors II 436,671 shares listed under Farallon funds on cover rows
Farallon Capital Partners (example) 188,360 shares listed under Farallon funds on cover rows
CUSIP 08659B102 Beta Bionics Common Stock CUSIP on cover
Execution date 05/12/2026 signature dates for filings
beneficial owner regulatory
"Amount beneficially owned: The information required by Items 4(a) - (c)"
A beneficial owner is the person who ultimately owns or controls a financial asset or property, even if their name isn't directly on official documents. Think of it like someone who secretly holds the keys to a safe deposit box—others may appear to have access, but the true owner is the one who benefits from what's inside. Identifying beneficial owners helps ensure transparency and prevent illegal activities like money laundering or fraud.
shared dispositive power regulatory
"Shared Dispositive Power 2,560,220.00"
Section 240.13d-1(c) regulatory
"The Reporting Persons are filing this pursuant to Section 240.13d-1(c)."
Joint Acquisition Statement regulatory
"Exhibit 1. Joint Acquisition Statement Pursuant to Section 240.13d-1(k)"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





08659B102

(CUSIP Number)
03/31/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Zone Healthcare Holdings, LLC
Signature:/s/ Hannah E. Dunn
Name/Title:Hannah E. Dunn, Managing Member of its Manager
Date:05/12/2026
Farallon Capital Partners, L.P.
Signature:/s/ Hannah E. Dunn
Name/Title:Hannah E. Dunn, Managing Member of its General Partner
Date:05/12/2026
Farallon Capital Institutional Partners, L.P.
Signature:/s/ Hannah E. Dunn
Name/Title:Hannah E. Dunn, Managing Member of its General Partner
Date:05/12/2026
Farallon Capital Institutional Partners II, L.P.
Signature:/s/ Hannah E. Dunn
Name/Title:Hannah E. Dunn, Managing Member of its General Partner
Date:05/12/2026
Farallon Capital Institutional Partners III, L.P.
Signature:/s/ Hannah E. Dunn
Name/Title:Hannah E. Dunn, Managing Member of its General Partner
Date:05/12/2026
Four Crossings Institutional Partners V, L.P.
Signature:/s/ Hannah E. Dunn
Name/Title:Hannah E. Dunn, Manager of its General Partner
Date:05/12/2026
Farallon Capital Offshore Investors II, L.P.
Signature:/s/ Hannah E. Dunn
Name/Title:Hannah E. Dunn, Managing Member of its General Partner
Date:05/12/2026
Farallon Capital (AM) Investors, L.P.
Signature:/s/ Hannah E. Dunn
Name/Title:Hannah E. Dunn, Managing Member of its General Partner
Date:05/12/2026
Farallon Capital F5 Master I, L.P.
Signature:/s/ Hannah E. Dunn
Name/Title:Hannah E. Dunn, Manager of its General Partner
Date:05/12/2026
Farallon Capital Management, L.L.C.
Signature:/s/ Hannah E. Dunn
Name/Title:Hannah E. Dunn, Managing Member
Date:05/12/2026
Farallon Partners, L.L.C.
Signature:/s/ Hannah E. Dunn
Name/Title:Hannah E. Dunn, Managing Member
Date:05/12/2026
Farallon F5 (GP), L.L.C.
Signature:/s/ Hannah E. Dunn
Name/Title:Hannah E. Dunn, Manager
Date:05/12/2026
Farallon Institutional (GP) V, L.L.C.
Signature:/s/ Hannah E. Dunn
Name/Title:Hannah E. Dunn, Manager
Date:05/12/2026
Dapice Joshua J.
Signature:/s/ Hannah E. Dunn
Name/Title:Hannah E. Dunn, as attorney-in-fact
Date:05/12/2026
Dreyfuss, Philip D.
Signature:/s/ Hannah E. Dunn
Name/Title:Hannah E. Dunn, as attorney-in-fact
Date:05/12/2026
Dunn Hannah E.
Signature:/s/ Hannah E. Dunn
Name/Title:Hannah E. Dunn
Date:05/12/2026
Gehani, Varun N.
Signature:/s/ Hannah E. Dunn
Name/Title:Hannah E. Dunn, as attorney-in-fact
Date:05/12/2026
Giauque, Nicolas
Signature:/s/ Hannah E. Dunn
Name/Title:Hannah E. Dunn, as attorney-in-fact
Date:05/12/2026
Husen, Avner A.
Signature:/s/ Hannah E. Dunn
Name/Title:Hannah E. Dunn, as attorney-in-fact
Date:05/12/2026
Kim, David T.
Signature:/s/ Hannah E. Dunn
Name/Title:Hannah E. Dunn, as attorney-in-fact
Date:05/12/2026
Linn, Michael G.
Signature:/s/ Hannah E. Dunn
Name/Title:Hannah E. Dunn, as attorney-in-fact
Date:05/12/2026
Luo Patrick (Cheng)
Signature:/s/ Hannah E. Dunn
Name/Title:Hannah E. Dunn, as attorney-in-fact
Date:05/12/2026
Roberts, Jr., Thomas G.
Signature:/s/ Hannah E. Dunn
Name/Title:Hannah E. Dunn, as attorney-in-fact
Date:05/12/2026
Saito Edric C.
Signature:/s/ Hannah E. Dunn
Name/Title:Hannah E. Dunn, as attorney-in-fact
Date:05/12/2026
Short Daniel S.
Signature:/s/ Hannah E. Dunn
Name/Title:Hannah E. Dunn, as attorney-in-fact
Date:05/12/2026
Spokes, Andrew J. M.
Signature:/s/ Hannah E. Dunn
Name/Title:Hannah E. Dunn, as attorney-in-fact
Date:05/12/2026
Warren, John R.
Signature:/s/ Hannah E. Dunn
Name/Title:Hannah E. Dunn, as attorney-in-fact
Date:05/12/2026
Wehrly, Mark C.
Signature:/s/ Hannah E. Dunn
Name/Title:Hannah E. Dunn, as attorney-in-fact
Date:05/12/2026
Exhibit Information

Exhibit 1. Joint Acquisition Statement Pursuant to Section 240.13d-1(k) (previously filed)

FAQ

What ownership stakes does BBNX show for Zone Healthcare Holdings in this 13G/A?

Zone Healthcare Holdings, LLC is reported as holding 2,560,220 shares (5.8%). The filing shows voting and dispositive powers for these shares in the cover-page rows referenced by Item 4.

What stake do the Farallon Individual Reporting Persons report in BBNX?

Each Farallon Individual Reporting Person is reported with 3,607,920 shares (8.1%) as reflected in the incorporated cover-page rows. The filing attributes shared dispositive power to those holdings.

Does this filing declare a formal group or change voting control for BBNX?

The Reporting Persons state they are filing pursuant to Section 240.13d-1(c) and "neither disclaim nor affirm the existence of a group." Each Reporting Person is shown as beneficial owner only of the securities reported by it.

Who signed the Schedule 13G/A amendment for BBNX and when?

The amendment is signed multiple times by Hannah E. Dunn in her managing roles, with signature dates of 05/12/2026 shown for the filings incorporated by reference.